
1. malar j. 2017 may 23;16(1):217. doi: 10.1186/s12936-017-1868-y.

molecular markers anti-malarial drug resistance central, west east
african children severe malaria.

nguetse cn(1), adegnika aa(1)(2), agbenyega t(3)(4), ogutu br(5), krishna
s(1)(6), kremsner pg(1)(2), velavan tp(7)(8)(9)(10).

author information: 
(1)institute tropical medicine, university tübingen, wilhelmstrasse 27, 72074,
tübingen, germany.
(2)centre de recherches médicales de lambaréné, lambaréné, gabon.
(3)department physiology, university science technology, school of
medical sciences, kumasi, ghana.
(4)departments child health medicine, komfo anokye teaching hospital,
kumasi, ghana.
(5)centre clinical research, kenya medical research institute, kisumu, kenya.
(6)institute infection immunity, st george's university london,
london, uk.
(7)institute tropical medicine, university tübingen, wilhelmstrasse 27, 72074,
tübingen, germany. velavan@medizin.uni-tuebingen.de.
(8)fondation congolaise pour la recherche médicale, brazzaville, republic of
congo. velavan@medizin.uni-tuebingen.de.
(9)vietnamese-german center medical research, hanoi, vietnam.
velavan@medizin.uni-tuebingen.de.
(10)faculty medicine, duy tan university, da nang, vietnam.
velavan@medizin.uni-tuebingen.de.

background: plasmodium falciparum multidrug resistance 1 (pfmdr1), p.
falciparum ca2+-atpase (pfatp6) kelch-13 propeller domain (pfk13) loci are
molecular markers parasite susceptibility anti-malarial drugs. their
frequency distributions determined isolates collected children
with severe malaria originating three african countries.
methods: samples 287 children severe malaria [(gabon: n = 114); (ghana:
n = 89); (kenya: n = 84)] genotyped pfmdr1, pfatp6 pfk13 loci dna
sequencing assessing pfmdr1 copy number variation (cnv) real-time pcr.
results: pfmdr1-n86y mutation detected 48, 10 10% lambaréné, kumasi
and kisumu, respectively. codon 184, prevalence mutation 73% in
lambaréné, 63% kumasi 49% kisumu. s1034c n1042d variants were
absent three sites, frequency d1246y mutation 1, 3
and 13% lambaréné, kumasi kisumu, respectively. isolates two pfmdr1
gene copy number predominantly harboured n86y wild-type allele were
mostly found kumasi (10%) (p < 0.0001). among main pfmdr1 haplotypes (nfd,
nyd yfd), nyd associated highest parasitaemia (p = 0.04). the
pfatp6 locus, h243y a623e mutations observed low frequency at
all three sites. prevalence pfatp6 e431k variant 6, 18 17% 
lambaréné, kumasi kisumu, respectively. l263e s769n mutations were
absent isolates. pfk13 variants associated artemisinin resistance
in southeast asia observed. eleven novel substitutions pfk13
locus occurring low frequency observed.
conclusions: artemisinins still highly efficacious large malaria-endemic
regions though declining efficacy occurred southeast asia. return of
chloroquine-sensitive strains following removal drug pressure observed.
however, selection wild-type alleles multidrug-resistance gene 
increased gene copy number associated reduced lumefantrine sensitivity.
this study indicates need constantly monitor drug resistance artemisinin 
in field isolates malaria-endemic countries.

doi: 10.1186/s12936-017-1868-y 
pmcid: pmc5442681
pmid: 28535801  [indexed medline]

